Predictors of Favourable Response to Cardiac Resynchronization Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Narrative Review
Open Access
- 3 October 2026
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2239
Abstract
Cardiac resynchronization therapy (CRT) is an effective treatment for selected patients with heart failure with reduced ejection fraction, but 30–40% of recipients do not respond. This narrative review summarizes predictors of a favourable response to CRT. Typical left bundle branch block (LBBB) and a QRS duration ≥ 150 ms remain the best-established baseline predictors. Sex, etiology, age and comorbidities affect how much benefit is gained rather than acting as yes/no predictors (the benefit is greater in women, partly because of their smaller heart size) and should not by themselves exclude an otherwise eligible patient. QRS duration indexed to left ventricular size, advanced electrocardiographic markers (QRS notching, intrinsicoid deflection, QRmax, QRS area) and echocardiographic markers of mechanical dyssynchrony (apical rocking, septal flash, the classical LBBB strain pattern, systolic stretch index, mechanical dispersion and myocardial work) have been linked to response in observational studies and may add prognostic information. Combining mechanical dyssynchrony with septal viability on cardiac magnetic resonance appears to improve selection further. Procedure-related factors, including left ventricular lead position and a high percentage of biventricular pacing, are critical for success. A multimodal approach that combines clinical, electrocardiographic, echocardiographic and imaging data, supported in the future by machine learning, appears most promising.Keywords
This publication has 102 references indexed in Scilit:
- Cardiac Resynchronization Therapy: Reconsidering Its Essence as a Treatment for Electrical Dyssynchrony in Heart FailureJournal of Arrhythmia, 2026
- Comorbidities and Clinical Response to Cardiac Resynchronization Therapy: Patient-Level Meta-Analysis from Eight Clinical TrialsEuropean Journal of Heart Failure, 2023
- 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failureJournal of Arrhythmia, 2023
- The role of cardiac magnetic resonance in identifying appropriate candidates for cardiac resynchronization therapy — a systematic review of the literatureHeart Failure Reviews, 2022
- Non-infective left ventricular lead complications requiring re-intervention following cardiac resynchronization therapy: prevalence, causes and outcomesJournal of Interventional Cardiac Electrophysiology, 2021
- Reduzierter biventrikulärer Stimulationsanteil durch ExtrasystolenHerzschrittmachertherapie + Elektrophysiologie, 2021
- The QR-max index, a novel electrocardiographic index for the determination of left ventricular conduction delay and selection of cardiac resynchronization in patients with non-left bundle branch blockJournal of Interventional Cardiac Electrophysiology, 2019
- Association of QRS narrowing with response to cardiac resynchronization therapy—a systematic review and meta-analysis of observational studiesHeart Failure Reviews, 2019
- Left ventricular global longitudinal strain and mechanical dispersion predict response to multipoint pacing for cardiac resynchronization therapyJournal of Clinical Ultrasound, 2019
- The Interaction of Sex, Height, and QRS Duration on the Effects of Cardiac Resynchronization Therapy on Morbidity and Mortality: An Individual-Patient Data Meta-AnalysisEuropean Journal of Heart Failure, 2018